Alerts will be sent to your verified email
Verify Email
ADVENZYMES
|
Advanced Enzyme
|
Eris Lifesciences
|
Parag Milk Foods
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
4.0 % | 0.0 | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
13.27 % | 21.87 % | -12.48 % |
|
5yr average Equity Multiplier
|
1.17 | 1.23 | 2.0 |
|
5yr Average Asset Turnover Ratio
|
0.44 | 0.65 | 1.49 |
|
5yr Avg Net Profit Margin
|
25.36 % | 27.87 % | -2.77 % |
|
Price to Book
|
3.54 | 5.03 | 2.95 |
|
P/E
|
32.26 | 31.36 | 24.44 |
|
5yr Avg Cash Conversion Cycle
|
87.78 Days | -52.94 Days | 50.02 Days |
|
Inventory Days
|
69.99 Days | 26.19 Days | 88.99 Days |
|
Days Receivable
|
63.55 Days | 46.91 Days | 17.93 Days |
|
Days Payable
|
53.39 Days | 168.01 Days | 54.26 Days |
|
5yr Average Interest Coverage Ratio
|
52.02 | 96.59 | 0.8 |
|
5yr Avg ROCE
|
17.59 % | 24.86 % | 0.03 % |
|
5yr Avg Operating Profit Margin
|
42.68 % | 36.16 % | 2.33 % |
|
5 yr average Debt to Equity
|
0.02 | 0.11 | 0.56 |
|
5yr CAGR Net Profit
|
-1.0 % | 5.62 % | -15.1 % |
|
5yr Average Return on Assets
|
11.36 % | 18.27 % | -3.96 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.49 % | 54.9 % | 42.61 % |
|
Share Pledged by Promoters
|
0.0 | 18.51 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-11.89 % | 0.77 % | -3.59 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.79 % | 5.69 % | 0.07 % |
|
Advanced Enzyme
|
Eris Lifesciences
|
Parag Milk Foods
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|
